Red Dye No. 3 Is Leaving Food Because of One Old Safety Clause

The cherry on a sundae is on a deadline. In January 2025, the U.S. Food and Drug Administration formally revoked the authorization of FD&C Red No. 3 — the vivid cherry-red dye, also called erythrosine, that colors maraschino cherries, some candies and cake decorations, and certain cherry-flavored medicines. Food manufacturers have until January 15, 2027 to reformulate; makers of ingested drugs have until January 18, 2028. The color of the drugstore aisle will quietly shift as those dates pass. And while patients measurably react when a medicine's color changes, this particular change is arriving with unusual calm — because the story behind it is a legal clause, not a poisoning scare.

What the order actually does

Reading the Federal Register entry, the scope is precise. The order repeals the regulations permitting Red No. 3 in foods, including dietary supplements, and in drugs that are swallowed. Cosmetics and externally applied drugs are untouched — not because anyone relisted them, but because their authorizations were already terminated back in 1990. Dye manufacturers may no longer ship batches certified after the deadlines, which is how a color exits a national food supply without a single product recall: existing stock simply sells through while recipes migrate to other colors, Red No. 40 among the most common.

How a synthetic color gets its papers

Red No. 3 belongs to a category the FDA calls certifiable color additives: synthetic dyes listed in the regulations, every batch of which must be chemically tested and certified by the agency before it may legally enter food, drugs, or cosmetics. That is what the initials in its name encode — FD&C marks a dye eligible for food, drug, and cosmetic use under the certification scheme, with separate listing sections for each application. A batch that passes gets a certification lot; a batch that fails never leaves the plant. This is why the 2025 order reads the way it does — it is not a recall and not a seizure, but an amendment to the list of colors for which certification will be granted. Once the deadlines pass, no new batch of Red No. 3 can earn certification for food or ingested-drug use, and the supply drains from the system through ordinary inventory. The machinery is quiet by design: a color can exit the national diet through paperwork alone.

The clause with no arithmetic

The engine of the decision is the Delaney clause, a 1958 provision of the Federal Food, Drug, and Cosmetic Act that deems a food or color additive unsafe if it is “found to induce cancer when ingested by man or animal.” The clause contains no risk-assessment arithmetic — no “unless the dose is tiny,” no extrapolation to humans, no cost-benefit balance. The FDA's order walks through exactly this tension. Male rats fed high doses of erythrosine in laboratory studies developed thyroid tumors; the agency's document acknowledges that other expert bodies had concluded the tumors arise through rodent-specific physiology and that risk to humans at actual exposure levels is unlikely. Under ordinary risk-based rules, that might have been the end of it. Under the Delaney clause, the tumor finding alone triggers revocation. The rule, in effect, is the mechanism: the color is leaving not because scientists declared it dangerous at the doses people eat, but because a sixty-year-old law refuses to do that math at all.

Red No. 3 versus Red No. 40

Shoppers understandably blur the numbers, so it helps to separate the two. Red No. 3 (erythrosine) is a fluorescein-based dye with iodine atoms in its structure — the reason some old chemistry-class demonstrations glow under ultraviolet light. Red No. 40 (Allura Red) is an entirely different molecule, an azo dye, and it remains authorized; the vast majority of “red” American food already uses it. Nothing in the 2025 order touches Red No. 40, caramel color, beet juice, or cochineal-based carmine. Biology supplies one extra wrinkle worth knowing: the tumor findings that mattered legally came from rats dosed at levels far above any diet, which is precisely the gap between “induces cancer in a feeding study” and “harms people at the amounts actually consumed” — the gap the Delaney clause was written to ignore.

Reading a label after the change

For a few years the transition will be visible on shelves. A jar of cherries reformulated for 2027 may look a shade different — the replacements land at slightly different hues and lightness — and drug products will take longest, since pharmaceutical color changes ripple through packaging approvals and pharmacy familiarity. Manufacturers have known since the order was signed which alternatives they would reach for, and the reformulations are already moving through product lines, which is why some shoppers are meeting the new reds early. It is not the first time the law has picked food colors outright; margarine spent decades restricted to unappetizing white by statute, and butter's yellow itself is a pigment story. If you want to sharpen your eye for where one red ends and another begins before the labels start moving, the Red or Orange? game is a quick calibration — the dye aisle is about to become a live test of it.